1,305
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Immunohistochemical study of MMP-2, MMP-9, EGFR and IL-8 in decidual and trophoblastic specimens of recurrent pregnancy loss cases

, , , , , & show all
Article: 2218523 | Received 30 Apr 2022, Accepted 22 May 2023, Published online: 31 May 2023

References

  • Kavvadas D, Karachrysafi S, Anastasiadou P, et al. Immunohistochemical evaluation of CD3, CD4, CD8, and CD20 in decidual and trophoblastic tissue specimens of patients with recurrent pregnancy loss. Clin Pract. 2022;12(2):177–193.
  • Papamitsou T, Fotiadou S, Papadopoulou K, et al. Evaluation of VEGF, BCL-2, BCL-6 by immunohistochemistry in the endometrial tissue of patients with recurrent pregnancy loss. Arch Hell Med. 2021;38(2):224–230.
  • Anumba DO, El Gelany S, Elliott SL, et al. Circulating levels of matrix proteases and their inhibitors in pregnant women with and without a history of recurrent pregnancy loss. Reprod Biol Endocrinol. 2010;8(1):62.
  • Hulboy DL, Rudolph LA, Matrisian LM. Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod. 1997;3(1):27–45.
  • Goldman S, Shalev E. The role of the matrix metalloproteinases in human endometrial and ovarian cycles. Eur J Obstet Gynecol Reprod Biol. 2003;111(2):109–121.
  • Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. IJMS. 2020;21(24):9739.
  • Zhu J-Y, Pang Z-J, Yu Y-H. Regulation of trophoblast invasion: the role of matrix metalloproteinases. Rev Obstet Gynecol. 2012;5(3–4):e137-43.
  • Niu R, Okamoto T, Iwase K, et al. Quantitative analysis of matrix metalloproteinases-2 and -9, and their tissue inhibitors-1 and -2 in human placenta throughout gestation. Life Sci. 2000;66(12):1127–1137.
  • Shiomi T, Lemaître V, D'Armiento J, et al. Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases. Pathol Int. 2010;60(7):477–496.
  • Voldborg BR, Damstrup L, Spang-Thomsen M, et al. Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Ann Oncol. 1997;8(12):1197–1206.
  • Liu L, Gong Y. LncRNA-TCL6 promotes early abortion and inhibits placenta implantation via the EGFR pathway. Eur Rev Med Pharmacol Sci. 2018;22(21):7105–7112.
  • Maruo T, Matsuo H, Otani T, et al. Role of epidermal growth factor (EGF) and its receptor in the development of the human placenta. Reprod Fertil Dev. 1995;7(6):1465–1470.
  • Ehsani V, Mortazavi M, Ghorban K, et al. Role of maternal interleukin-8 (IL-8) in normal-term birth in the human. Reprod Fertil Dev. 2019;31(6):1049–1056.
  • Caballero-Campo P, Domínguez F, Coloma J, et al. Hormonal and embryonic regulation of chemokines IL-8, MCP-1 and RANTES in the human endometrium during the window of implantation. Mol Hum Reprod. 2002;8(4):375–384.
  • Pitman H, Innes BA, Robson SC, et al. Altered expression of interleukin-6, interleukin-8 and their receptors in decidua of women with sporadic miscarriage. Hum Reprod. 2013;28(8):2075–2086.
  • García-Velasco JA, Arici A. Chemokines and human reproduction. Fertil Steril. 1999;71(6):983–993.
  • Sharma S, Godbole G, Modi D. Decidual control of trophoblast invasion. Am J Reprod Immunol. 2016;75(3):341–350.
  • Dimitriadis E, Menkhorst E, Saito S. Recurrent pregnancy loss. Nat Rev Dis Prim. 2020;6(1):98.
  • Kyratzoulis E, Kaletzi P, Chatzimichail F, et al. Immunohistochemical study of IL-10 and CD46 in placental tissues in recurrent pregnancy loss. Aristotle Biomed J. 2022;4(1):1–6.
  • Fedchenko N, Reifenrath J. Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue – a review. Diagn Pathol. 2014;9:221.
  • Yavasoglu I, Sargin G, Kadikoylu G, et al. Immunohistochemical evaluation of CD20 expression in patients with multiple myeloma. Rev Bras Hematol Hemoter. 2015;37(1):34–37.
  • Papadopoulos E, Nikolaidou C, Kotini A, et al. A comparative immunohistochemical investigation of the consequences of chorioamnionitis on the developing human fetal spleen. Clin Exp Obstet Gynecol. 2017;44(1):30–38.
  • Liu C, Gao Y, Guo Y. Relationship between the matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-3 in decidua tissue and spontaneous abortion. J Clin Exp Pathol. 2004;20:551–553.
  • Nissi R, Talvensaari-Mattila A, Kotila V, et al. Circulating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancy failure. Reprod Biol Endocrinol. 2013;11(1):2.
  • Sundrani DP, Chavan-Gautam PM, Pisal HR, et al. Matrix metalloproteinase-1 and -9 in human placenta during spontaneous vaginal delivery and caesarean sectioning in preterm pregnancy. Schunck W-H, editor. PLoS One. 2012;7(1):e29855.
  • Hastie R, Brownfoot FC, Pritchard N, et al. EGFR (epidermal growth factor receptor) signaling and the mitochondria regulate sFlt-1 (soluble FMS-Like tyrosine kinase-1) secretion. Hypertension. 2019;73(3):659–670.
  • Su MT, Lin SH, Chen YC, et al. Gene-gene interactions and gene polymorphisms of VEGFA and EG-VEGF gene systems in recurrent pregnancy loss. J Assist Reprod Genet. 2014;31(6):699–705.
  • Zheng Q, Li Y, Zhang D, et al. ANP promotes proliferation and inhibits apoptosis of ovarian granulosa cells by NPRA/PGRMC1/EGFR complex and improves ovary functions of PCOS rats. Cell Death Dis. 2017;8(10):e3145–e3145.
  • Reyes HD, Thiel KW, Carlson MJ, et al. Comprehensive profiling of EGFR/HER receptors for personalized treatment of gynecologic cancers. Mol Diagn Ther. 2014;18(2):137–151.
  • Balci M, Ozdemir G. Differential expression of egfr-1, mmp-3, and mmp-9 in spontaneous abortions, induced abortions, and tubal pregnancies. Turkish J Pathol. 2018;35(1):1–8.
  • De Oliveira LG, Lash GE, Murray-Dunning C, et al. Role of interleukin 8 in uterine natural killer cell regulation of extravillous trophoblast cell invasion. Placenta. 2010;31(7):595–601.